Ertapenem for treatment of osteomyelitis: A case series

BMC Research Notes

Volumn 4, Issue , 2011, Pages

  Goswami, Neela D ^a   Johnson, Melissa D ^a   Chu, Vivian H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NICOTIANA TABACUM;

EID: 80055110611     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-4-478     Document Type: Article

References (14)

1. Probe-to-bone test for diagnosing diabetic foot osteomyelitis: reliable or relic? Lavery LA, Armstrong DG, Peters EJ, Lipsky BA, Diabetes Care 2007 30 2 270 4 10.2337/dc06-1572 17259493 (Pubitemid 46198329)
2. Oral antimicrobial therapy for diabetic foot osteomyelitis. Embil JM, Rose G, Trepman E, Math MC, Duerksen F, Simonsen JN, et al. Foot Ankle Int 2006 27 10 771 9 17054876 (Pubitemid 44497843)
3. The treatment of diabetic foot infections: focus on ertapenem. Edmonds M, Vasc Health Risk Manag 2009 5 949 63 19997576
4. Safety and tolerability of ertapenem. Teppler H, Gesser RM, Friedland IR, Woods GL, Meibohm A, Herman G, et al. J Antimicrob Chemother 2004 53 Suppl 2 i75 81 15150186
5. The use of ertapenem for the treatment of lower extremity infections. Nielsen MD, Mendicino RW, Catanzariti AR, J Foot Ankle Surg 2009 48 2 135 41 10.1053/j.jfas.2008.11.008 19232964
6. Ertapenem: a new opportunity for outpatient parenteral antimicrobial therapy. Tice AD, J Antimicrob Chemother 2004 53 Suppl 2 i83 6 15150187
7. Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial. Lipsky BA, Armstrong DG, Citron DM, Tice AD, Morgenstern DE, Abramson MA, Lancet 2005 366 9498 1695 703 10.1016/S0140-6736(05)67694-5 16291062 (Pubitemid 41587448)
8. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia. Lalani T, Boucher HW, Cosgrove SE, Fowler VG, Kanafani ZA, Vigliani GA, et al. J Antimicrob Chemother 2008 61 1 177 82 17999973
9. Outcome of diabetic foot infections treated conservatively: a retrospective cohort study with long-term follow-up. Pittet D, Wyssa B, Herter-Clavel C, Kursteiner K, Vaucher J, Lew PD, Arch Intern Med 1999 159 8 851 6 10.1001/archinte.159.8.851 10219931 (Pubitemid 29200312)
10. Efficacy of ertapenem for consolidation therapy of extended-spectrum beta-lactamase-producing gram-negative infections: a case series report. Berg ML, Crank CW, Philbrick AH, Hayden MK, Ann Pharmacother 2008 42 2 207 12 10.1345/aph.1K365 18230703 (Pubitemid 351238568)
11. Culture of percutaneous bone biopsy specimens for diagnosis of diabetic foot osteomyelitis: concordance with ulcer swab cultures. Senneville E, Melliez H, Beltrand E, Legout L, Valette M, Cazaubiel M, et al. Clin Infect Dis 2006 42 1 57 62 10.1086/498112 16323092 (Pubitemid 41832080)
12. Outcome of diabetic foot osteomyelitis treated nonsurgically: a retrospective cohort study. Senneville E, Lombart A, Beltrand E, Valette M, Legout L, Cazaubiel M, et al. Diabetes Care 2008 31 4 637 42 10.2337/dc07-1744 18184898
13. Needle puncture and transcutaneous bone biopsy cultures are inconsistent in patients with diabetes and suspected osteomyelitis of the foot. Senneville E, Morant H, Descamps D, Dekeyser S, Beltrand E, Singer B, et al. Clin Infect Dis 2009 48 7 888 93 10.1086/597263 19228109
14. Can aggressive treatment of diabetic foot infections reduce the need for above-ankle amputation? Tan JS, Friedman NM, Hazelton-Miller C, Flanagan JP, File TM Jr, Clin Infect Dis 1996 23 2 286 91 10.1093/clinids/23.2.286 8842265 (Pubitemid 26264911)